logo
logo

Nordic Bioscience Welcomes Investment from KKR for Next Phase of Growth

Mar 03, 2021•over 4 years ago
Copenhagen

Description

Nordic Bioscience A/S, a Danish company and world leader in biomarker development, announced today the signing of an investment from KKR, a leading global investment firm. KKR will acquire a minority equity stake in Nordic Bioscience from existing shareholders and will support the company in accelerating its global growth.

Company Information

Company

Dr. Claus Christiansen

Location

Copenhagen, Capital Region Of Denmark, Denmark

About

Dr. Claus Christiansen, together with his wife Dr. Bente Juel Riis, has during the last three decades founded and been involved with several successful biotechnology companies, including among others Osteometer, CCBR Synarc, Sanos Clinic, and Radius Health in addition to Nordic Bioscience. Dr. Christiansen is also the founder of Danish Research Foundation, which has distributed more than 250 million DKK to life science and natural sciences research projects, arts and culture and other miscellaneous projects.